← Back to Patent Explorer
US4532250A Expired / Lapsed US ⏱️ 0.0 years remaining

5-Heteroarylimidazol-2-ones having cardiotonic activity

Assignee: Bristol Myers Squibb Pharma Co
•
Filing: 1983-11-23
•
Granted: 1985-07-30
•
Expires: 2003-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Described are compounds of the formula ##STR1## wherein R is heteroaryl and R 1 is hydrogen or loweralkyl, or a pharmaceutically acceptable salt thereof. The compounds exhibit cardiotonic activity.

Inventors

  • 👤 David M. Stout
  • 👤 Diane M. Yamamoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-05 12:40
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/24; C07D213/44; C07D213/53; C07D213/46; C07D213/50; C07D401/00; C07D401/02; C07D401/04

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 63 words
A method of treating or relieving the symptoms associated with cardiac insufficiency in a patient by a selective increase in the cardiac contractile force comprising administering to a patient in need of such a treatment a therapeutically effective amount of a compound of the formula ##STR6## wherein R is pyridyl and R 1 is hydrogen or loweralkyl, or a pharmaceutically acceptable salt thereof.
Claim 2
Independent Claim 63 words
A method of treating or relieving the symptoms associated with cardiac insufficiency in a patient by a selective increase in the cardiac contractile force comprising administering to a patient in need of such a treatment a therapeutically effective amount of a compound of the formula ##STR6## wherein R is pyridyl and R 1 is hydrogen or loweralkyl, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 14 words
The method of claim 1 where R is pyridyl and R 1 is loweralkyl.
Claim 4
Dependent Claim 10 words
The method of claim 2 wherein R 1 is methyl.

References Cited (Backward Citations)

US3538104A Cited
US3850944A Cited
EP0059948A1 Cited
EP0078545A1 Cited
EP0078546A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-29 1989-01-28 1989-07-30 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-29 1993-01-28 1993-07-30 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-29 1997-01-28 1997-07-30 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag